This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Clevexel Pharma. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Itai Bloch: Innovator in Kinase Modulation
Introduction
Itai Bloch is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of biotechnology, particularly in the modulation of kinase signaling pathways. His innovative work has the potential to impact various therapeutic areas.
Latest Patents
Itai Bloch holds a patent titled "Compositions and methods for modulating a kinase." This invention relates to compounds and methods designed to modulate one or more components of a kinase signaling cascade. His patent represents a significant advancement in understanding and manipulating cellular signaling mechanisms.
Career Highlights
Itai Bloch is currently associated with Clevexel Pharma, a company focused on developing innovative therapies. His role at Clevexel Pharma allows him to apply his expertise in kinase modulation to real-world applications, contributing to the advancement of medical science.
Collaborations
Itai has collaborated with notable colleagues, including Oren Becker and Efrat Ben-Zeev. These partnerships enhance the research and development efforts at Clevexel Pharma, fostering a collaborative environment for innovation.
Conclusion
Itai Bloch's work in kinase modulation exemplifies the impact of innovative thinking in biotechnology. His contributions through patents and collaborations continue to pave the way for advancements in therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile